Health Care/Hospital

New Research Reassures & Advises Contact Lens Wearers During Coronavirus / COVID-19 Pandemic; Offers Clear Facts and Hygiene Advice

Peer-Reviewed Paper by Prominent Scientists Reinforces Need for Hand Washing, Warns that Wearing Glasses / Spectacles Does Not Reduce Risk of Infection WATERLOO, Ontario, April 13, 2020 /PRNewswire/ -- Moving swiftly to address and correct harmful myths and misinformation, a new peer-reviewed pap...

2020-04-13 20:00 4250

Antengene Corporation Appoints Former Celgene ANZ General Manager Thomas Karalis as Head of Asia Pacific Regions

SHANGHAI and MELBOURNE, Australia, April 13, 2020 /PRNewswire/ -- Antengene Corporation today announced the appointment of Mr. Thomas Karalis as Head of Asia Pacific Regions. In this position, Tom will be responsible for the commercialization of Antengene products inAustralia, New Zealand, S. Kor...

2020-04-13 20:00 3016

Ascletis Receives IND Approval for its HIV Drug ASC09F

HANGZHOU and SHAOXING, China, April 13, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today that it received IND approval from National Medical Products Administration (NMPA) for its human immunodeficiency virus (HIV) protease inhibitor ASC09F (ASC09/Ritonavir Fixed-Dose C...

2020-04-13 20:00 3154

Cyient Receives ISO 13485 Quality Certification for ASIC Design and Supply

The new certification is in addition to the ISO 13485 certifications the company has had for engineering since 2009 and manufacturing since 2007 and is a testament to its expertise in developing advanced ICs for the MedTech market. HYDERABAD, India, April 13, 2020 /PRNewswire/ -- Cyient, a global...

2020-04-13 17:23 1895

VISTA Eye Specialist Going Digital to Raise Awareness on Preventable Blindness.

KUALA LUMPUR, Malaysia, April 13, 2020 /PRNewswire/ -- Amidst the global effort to stem the spread of the COVID-19 virus, includingMalaysia adopting its own Movement Control Order (MCO), VISTA Eye Specialist is not holding back their effort in its "War against Blindness" campaign. In fact, VISTA ...

2020-04-13 08:00 2837

HUAWEI CLOUD and Malaysia Ministry of Health Jointly Help Sungai Buloh Hospital by Providing AI Solution to Combat COVID-19 Pandemic

KUALA LUMPUR, Malaysia, April 10, 2020 /PRNewswire/ -- Huawei Malaysia has joined hands with the Malaysia Ministry of Health to contribute Huawei Cloud AI-assisted Diagnosis solution to Sungai Buloh Hospital to empower local medical personnel with AI capabilities by providing an AI solution for C...

2020-04-10 21:31 4427

XCMG Exports Special Epidemic Prevention Equipment to the Middle East, Assisting Global Partners in Fighting COVID-19

XUZHOU, China, April 10, 2020 /PRNewswire/ -- XCMG (SHE:000425) has delivered an order of multi-functional dust suppression vehicles to theMiddle East on March 30, marking a new milestone as the company's first bulk export of the product. The deal was completed on XCMG's Machmall.com platform and...

2020-04-10 18:17 5804

Huami Partnered with Nanshan Zhong's Team to Combat COVID-19 Coronavirus on a Joint Lab

SHENZHEN, China, April 10, 2020 /PRNewswire/ -- Huami (NYSE: HMI), announced a collaboration with China National Clinical Research Center of Respiratory Disease (NCRCRD) and Guangdong Nanshan Medical Innovation Institute, led by Dr. Nanshan Zhong, to establish a smart wearable joint laboratory. B...

2020-04-10 17:49 4205

AGC to Expand Its Spanish Synthetic Pharmaceutical Production Base for Capacity Increase and Establishment of New R&D Facility

TOKYO, April 10, 2020 /PRNewswire/ -- AGC Inc. (AGC), a world-leading manufacturer of glass, chemicals and high-tech materials, has announced its decision to expand facilities at its synthetic pharmaceutical (*1) CDMO (*2) business subsidiary, AGC Pharma Chemicals Europe S. L. U., headquartered i...

2020-04-10 14:00 2049

Samsung Biologics and Vir Biotechnology Enter into Agreement for Large Scale Manufacture of SARS-COV-2 Antibodies for Potential COVID-19 Treatment

SONGDO, South Korea and SAN FRANCISCO, April 9, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and Vir Biotechnology, Inc. (Nasdaq: VIR) today announced a manufacturing agreement under which Samsung Biologics will perform large scale manufacturing services for Vir's SARS-CoV-2 monoclonal anti...

2020-04-10 11:39 2453

Estonia's Public and Private Sectors Come Together in E-Hackathon to Develop Innovative Solutions Admist the Crisis

TALLINN, Estonia, April 9, 2020 /PRNewswire/ -- On the day the state of emergency was declared inEstonia, a public-private e-hackathon was held as one of the first crisis responses to offer quick and feasible solutions to combat the impacts of COVID-19 outbreak. Estonia has a number of digital an...

2020-04-09 21:44 2281

JNCCN: Improving COVID-19 Safety for Cancer Patients and Healthcare Providers

PLYMOUTH MEETING, Pennsylvania, April 9, 2020 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers--is continuing to share new resources for optimal cancer management amid new and changing challenges related to the Coronavirus Disease 2019 (COVI...

2020-04-09 20:35 1680

Seneca Biopharma Announces Results of Meeting with FDA Regarding the Design of Phase 3 Trial for NSI-566 in ALS

GERMANTOWN, Maryland, April 9, 2020 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq: SNCA), a clinical-stage biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need, today announced that the company held a Type C meeting with the Office of Tissues a...

2020-04-09 20:00 3065

Excelra Releases COVID-19 Drug Repurposing Database to Support Global Drug Development Efforts Against Novel Coronavirus

HYDERABAD, India, April 9, 2020 /PRNewswire/ -- Excelra, a leading global data and analytics company, today announced the release of the COVID-19 Drug Repurposing Database ( https://www.excelra.com/covid-19-drug-repurposing-database/ )....

2020-04-09 19:36 2548

Diageo donates ethyl alcohol to help combat COVID-19 in Southeast Asia

SINGAPORE, April 9, 2020 /PRNewswire/ -- Diageo, a global leader in beverage alcohol, has pledged to donate neutral spirit - a 96% strength ethyl alcohol used primarily in production of alcohol beverages, in support of efforts in Southeast Asia to tackle the challenge of COVID-19.

2020-04-09 19:11 2878

Merck and Pfizer Receive US FDA Breakthrough Therapy Designation and Submit Application for BAVENCIO(R) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma

Not intended for US-, Canada- and UK-based media  -  Breakthrough Therapy Designation and Submission based on positive Phase III JAVELIN Bladder 100 study results -  Supplemental Biologics License Application being reviewed under FDA Real-Time Oncology Review (RTOR) pilot program -  JAVELIN B...

2020-04-09 18:00 4865

Infineon delivers millions of chips for medical ventilators

MUNICH, Germany, April 9, 2020 /PRNewswire/ -- Infineon Technologies AG (FSE: IFX / OTCQX: IFNNY) is playing a vital role to support the manufacturing of ventilator devices. Power semiconductors from Infineon are essential to reliably and efficiently control the motor of the ventilators, includin...

2020-04-09 16:05 5302

World-First Trial to Test Benefit of Intravenous Zinc in COVID-19 Fight

SYDNEY, April 9, 2020 /PRNewswire/ -- A world-first trial will see researchers from Austin Health and theUniversity of Melbourne use intravenous zinc to fight the symptoms of coronavirus (COVID-19). The trial will be led by Austin Health's Dr Joseph Ischia and Dr Oneel Patel from the Department ...

2020-04-09 15:57 1197

EHR Investments Increase as Governments and Healthcare Authorities Focus on Interoperability

Europe will see more partnerships for integrated care from the evolution of electronic health records, finds Frost & Sullivan LONDON, April 9, 2020 /PRNewswire/ -- The electronic medical record (EMR) market is likely to register impressive growth acrossEurope as it evolves into a morecomprehensi...

2020-04-09 15:50 1980

Bridge Biotherapeutics Discloses Interim Results from the First Cohort of Phase 2a Study of BBT-401, an Experimental Drug for Ulcerative Colitis

* The Interim data showed that 3 out of 9 evaluable patients on BBT-401 responded with more than 30% reduction in Total Mayo Score or 25% reduction in Partial Mayo Score * Safety and tolerability profiles remain consistent with results from Phase I trial in healthy volunteers SEONGNAM, South ...

2020-04-09 15:14 1207
1 ... 698699700701702703704 ... 807